CURRENT DILEMMAS IN LIVER DISEASE AND EFFECTIVE TREATMENT APPROACHES In September 2015, Houston Methodist hosted the second annual Emerging Topics in Liver Disease Conference. The conference was conceived and hosted by Victor Ankoma-Sey, MD, medical director of liver transplant. Entitled Innovative Trends in Liver Health, the day-long event provided insight into impending developments in hepatology and new approaches to the management of liver diseases. Ashish Saharia, MD, associate director, kidney and pancreas transplant
A group of nationally renowned experts focused on four primary areas: hot topics in liver disease, end-stage liver disease, chronic viral hepatitis and primary care concerns. The new findings in liver disease were presented in a clinical context, beneficial in the multidisciplinary management of unique and complex liver disorders. “The conference is a mixture of case presentations and lectures, panel discussions and debates about current issues in the treatment of liver disease,” said AnkomaSey. “It is an interactive conference with an audience response system that allows participants to ask questions and respond to polls.” Attendees learned about the natural history and outcome of fatty liver disease and its relationship to patient management, as well as how to evaluate current therapeutic modalities and develop more effective treatment algorithms for hepatitis C and B patients. Participants identified the current and potential emerging therapies for specific liver diseases and discussed the dilemmas facing clinicians who are treating patients with end-stage liver diseases.
From left: R. Mark Ghobrial, MD, PhD; Sherilyn Gordon Burroughs, MD; Ashish Saharia, MD
houstonmethodist.org/transplant